NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 17 filers reported holding NOVUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $720,000 | +147.4% | 758,149 | +19.3% | 0.00% | – |
| Q2 2020 | $291,000 | +63.5% | 635,280 | +38.9% | 0.00% | – |
| Q1 2020 | $178,000 | -32.6% | 457,324 | +0.3% | 0.00% | – |
| Q4 2019 | $264,000 | +11.4% | 455,736 | +19.2% | 0.00% | – |
| Q3 2019 | $237,000 | -42.8% | 382,236 | -6.6% | 0.00% | – |
| Q2 2019 | $414,000 | -49.0% | 409,456 | +102.8% | 0.00% | -100.0% |
| Q1 2019 | $812,000 | +117.1% | 201,906 | -13.6% | 0.00% | – |
| Q4 2018 | $374,000 | -68.2% | 233,802 | -7.1% | 0.00% | -100.0% |
| Q3 2018 | $1,175,000 | -38.9% | 251,556 | -17.6% | 0.00% | 0.0% |
| Q2 2018 | $1,923,000 | +247.1% | 305,464 | +178.0% | 0.00% | 0.0% |
| Q1 2018 | $554,000 | +46.2% | 109,876 | +17.8% | 0.00% | – |
| Q4 2017 | $379,000 | -13.3% | 93,276 | +11.2% | 0.00% | -100.0% |
| Q3 2017 | $437,000 | +19.1% | 83,876 | +33.6% | 0.00% | – |
| Q2 2017 | $367,000 | – | 62,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|